Placeholder Banner

Congressman Tom Suozzi to Spotlight Scientific and Economic Development Advancements in New York

July 27, 2018

Congressman Tom Suozzi will join leaders of New York’s biotechnology community for a tour of Alexandria LaunchLabs.

The group will discuss prospects for, and impediments to, the continued growth of this important New York industry.1 The Congressman also will discuss how federal biotech policy and budget debates could impact biomedical innovation.


Tour and Q&A at Alexandria LaunchLabs


Congressman Tom Suozzi

Ron Cohen, CEO, Acorda Therapeutics

Jim Greenwood, ​President & CEO, BIO

Jennifer Bland,​ CEO, NewYorkBIO

Other members of the New York bioscience community 



Monday, July 30, 2018 at 11:00 am



Alexandria LaunchLabs

430 East 29th Street

14th Floor

New York City, NY


Media requested to RSVP to George Goodno,




About Alexandria LaunchLabs

Alexandria LaunchLabs is the premier, full-service startup platform designed to dramatically accelerate the growth of early-stage life science startups. With its flagship site at the Alexandria Center® for Life Science – New York City and its Cambridge site at the Alexandria Center® at One Kendall Square, Alexandria LaunchLabs provides move-in ready office/laboratory space, first-class support resources, shared equipment and services, creative amenities and access to startup capital through the Alexandria Seed Capital Platform— all of which are critical for driving the growth of seed- and early-stage companies across the country. The Alexandria LaunchLabs team is currently accepting applications for future members in New York City and Cambridge. For more information or to apply, please visit

Discover More
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…